| Literature DB >> 34988307 |
Wanxue Wen1, Xiaoling Chen1, Zhiqing Huang1, Daiwen Chen1, Bing Yu1, Jun He1, Yuheng Luo1, Hui Yan1, Hong Chen2, Ping Zheng1, Jie Yu1.
Abstract
This study aimed to investigate effects of dietary lycopene supplementation on meat quality, antioxidant ability and muscle fiber type transformation in finishing pigs. In a 70-day experiment, 18 Duroc × Landrace × Yorkshire barrows were randomly allocated to 3 dietary treatments including a basal diet supplemented with 0, 100 and 200 mg/kg lycopene, respectively. Each dietary treatment had 6 replicates with one pig each. Results showed that dietary 200 mg/kg lycopene supplementation increased muscle redness a∗ value, intramuscular fat and crude protein contents, and decreased muscle lightness L∗ and yellowness b∗ values (P < 0.05), suggesting that addition of 200 mg/kg lycopene to the diet of finishing pigs improved color, nutritional value and juiciness of pork after slaughter. Results also showed that dietary lycopene supplementation enhanced antioxidant capacity of finishing pigs (P < 0.05). Moreover, dietary supplementation of 200 mg/kg lycopene significantly increased slow myosin heavy chain (MyHC) protein level and slow-twitch fiber percentage, and decreased fast MyHC protein level and fast-twitch fiber percentage (P < 0.05), suggesting that the addition of 200 mg/kg lycopene to the diet of finishing pigs promoted muscle fiber type conversion from fast-twitch to slow-twitch. Together, we provide the first evidence that dietary 200 mg/kg lycopene supplementation improves meat quality, enhances antioxidant capacity and promotes muscle fiber type transformation from fast-twitch to slow-twitch in finishing pigs.Entities:
Keywords: Antioxidant capacity; Finishing pig; Lycopene; Meat quality; Skeletal muscle fiber type transformation
Year: 2021 PMID: 34988307 PMCID: PMC8688882 DOI: 10.1016/j.aninu.2021.06.012
Source DB: PubMed Journal: Anim Nutr ISSN: 2405-6383
Feed ingredients and nutrient levels of the basal diet (%, air-dry basis).
| Item | Content |
|---|---|
| Ingredients | |
| Corn | 81.57 |
| Soybean meal | 11.48 |
| Soybean oil | 2.30 |
| Wheat bran | 2.00 |
| L-Lysine-HCl | 0.39 |
| DL-Methionine | 0.09 |
| L-Threonine | 0.13 |
| L-Tryptophan | 0.03 |
| Choline chloride | 0.10 |
| Limestone | 0.70 |
| Dicalcium phosphate | 0.68 |
| NaCl | 0.30 |
| Vitamin premix | 0.03 |
| Mineral premix | 0.20 |
| Total | 100.00 |
| Nutrient levels | |
| Digestible energy, Mcal/kg | 3.40 |
| Crude protein | 12.26 |
| Calcium | 0.54 |
| Total phosphorus | 0.43 |
| Available phosphorus | 0.24 |
| Lysine | 0.73 |
| Methionine | 0.26 |
| Threonine | 0.46 |
| Tryptophan | 0.13 |
Vitamin premix provides the following per kilogram of complete diet: vitamin A, 9,000 IU; vitamin D3, 3,000 IU; vitamin E, 24 IU; vitamin K3, 3 mg; vitamin B12, 0.036 mg; vitamin B1, 3 mg; vitamin B6, 3.6 mg; vitamin B2, 7.5 mg; vitamin B5, 15 mg; folic acid, 1.5 mg; biotin, 0.15 mg; nicotinamide, 30 mg.
Mineral premix provides the following per kilogram of complete diet: Se (Na2SeO3) 0.15 mg; I (KI) 0.14 mg; Zn (ZnSO4) 50 mg; Gu (CuSO4. 5H2O) 3 mg; Fe (FeSO4. H2O) 40 mg; Mn (MnSO4) 2 mg.
Primer sequences used in this study.
| Gene | Primer | Sequence (5′ to 3′) | GenBank ID | Size, bp |
|---|---|---|---|---|
| Forward | CTTCTACAGGCCTGGGCTTAC | NM_080728 | 128 | |
| Reverse | CTCCTTCTCAGACTTCCGCAG | |||
| Forward | TTCCAGAAGCCTAAGGTGGTC | NM_001039545 | 94 | |
| Reverse | GCCAGCCAGTGATGTTGTAAT | |||
| Forward | CAACCCATACGACTACGCCT | NM_030679 | 119 | |
| Reverse | CATCAGAAGTGAAGCCCAGAAT | |||
| Forward | CTTGTCTGACTCAAGCCTGCC | NM_010855 | 158 | |
| Reverse | TCGCTCCTTTTCAGACTTCCG | |||
| Forward | TGAAGCCAAATGCCTCCACAACAC | NM_006529382 | 155 | |
| Reverse | ACACCTTGTGCTTAGAGCCCAGTA | |||
| Forward | CGGCAAAGTGAAGGTTGG | NM_001167633 | 123 | |
| Reverse | AGGTTCTGAATTTCTCTGCGG | |||
| Forward | TGAGGTCGATATCTGGAGCTG | NM_214266 | 151 | |
| Reverse | AGTGGCAACAGAACGATTGAG | |||
| Forward | ACAGTGACAGTGGCACATGC | NM_019812 | 130 | |
| Reverse | AATCCAGATCCTCCAGCACA | |||
| Forward | CCAGTACAACAATGAGCCTGC | NM_008904 | 118 | |
| Reverse | CAATCCGTCTTCATCCACG | |||
| Forward | TGCGGAGTGTTAAACTTTTCAGG | NM_001129970 | 191 | |
| Reverse | TGCCTTAACAGGCTAGTGAACA | |||
| Forward | CCTTGTGGTGGGAGGAATGTT | XM_005657993 | 77 | |
| Reverse | AGTATGCTGGCTGACCTTGTG | |||
| Forward | GCTCTCCGTTCAGTTTTGCG | AY923074 | 187 | |
| Reverse | GGAAGTTCCCTCCACAGCTC | |||
| Forward | GCAAGCAGTGAAGCAGCTA | NM_001128475 | 82 | |
| Reverse | CAGACTGCCAGCTTTCCTTAC | |||
| Forward | AGCCCTCAACAGTGAAAGCA | NM_026444 | 174 | |
| Reverse | TCAATGGCTCCGATACTGCTG | |||
| Forward | GTGAGTCAGTCACCTTGAGC | NM_001025218 | 180 | |
| Reverse | TCTGGCCTACTCAGGAAGGA | |||
| Forward | AGACCTGGGCAATGTGACTG | NM_001190422 | 102 | |
| Reverse | GTGCGGCCAATGATGGAATG | |||
| Forward | TGAACAACCTGAACGTCGTG | NM_214127.2 | 102 | |
| Reverse | AGCGGTCAACTTCTCCTTGA | |||
| Forward | CAGATGAAGCATTGGAAGGAGC | NM_214301 | 83 | |
| Reverse | TTGTCTCCTATCGGATTCCCAG | |||
| Forward | GTGAATGGCGCAAATGCTCA | NM_214201 | 126 | |
| Reverse | ATTGCGACACACTGGAGACC | |||
| Forward | CCAACCCAGAAGACTGCTCA | AB000884 | 102 | |
| Reverse | CATTCAGGTGGGCTCTTCGT | |||
| Forward | GTGAGCCGACTGAACACCAT | XM_003483635 | 102 | |
| Reverse | CAGGATGTGAGGAGCTGTGT | |||
| Forward | GCCCCTGGAAGCGTTAAAC | XM_003133500 | 67 | |
| Reverse | GGACTGTATCCCCAGAAGGTTGT | |||
| Forward | ACGACGTGGAGACAGAAACGT | NM_001114671 | 56 | |
| Reverse | GCTTCGCCGATGCTTCA | |||
| Forward | ACTCACTCTTCTACCTTTGATGCT | NM_001206359 | 100 | |
| Reverse | TGTTGCTGTAGCCAAATTCA |
MyHC I = myosin heavy chain I; MyHC IIa = myosin heavy chain IIa; MyHC IIx = myosin heavy chain IIx; MyHCIIb = myosin heavy chain IIb; TNNI1 = troponin I type 1; AMPKα1 = AMP-activated protein kinase α1; AMPKα2 = AMP-activated protein kinase α2; Sirt1 = sirtuin1; PGC-1α = peroxisome proliferator activated receptor-γ coactivator-1α; Cytc = cytochrome c; NRF1 = nuclear respiratory factor 1; TFAM = mitochondrial transcription factor A; TFB1M = mitochondrial transcription factor B1; CS = citrate synthase; COX1 = cyclooxygenase 1; SOD1 = superoxide dismutase 1; SOD2 = superoxide dismutase 2; CAT = catalase; GPX1 = glutathione peroxidase 1; GST = glutathione S-transferase; GR = glutathione reductase; NRF2 = nuclear factor erythroid 2-related factor 2; Keap1 = Kelch-like ECH-associated protein 1; GAPDH = glyceraldehyde-3-phosphate dehydrogenase.
Effect of dietary lycopene supplementation on growth performance and carcass characteristics of finishing pigs.1
| Item | Lycopene, mg/kg | SEM | |||
|---|---|---|---|---|---|
| 0 | 100 | 200 | |||
| Initial weight, kg | 64.10 | 63.63 | 63.95 | 1.15 | 0.988 |
| Final weight, kg | 136.57 | 138.95 | 135.30 | 2.10 | 0.793 |
| ADG, kg/d | 1.04 | 1.08 | 1.02 | 0.01 | 0.553 |
| ADFI, kg/d | 3.34 | 3.31 | 3.18 | 0.05 | 0.469 |
| F:G | 3.22 | 3.09 | 3.13 | 0.03 | 0.322 |
| Carcass weight, kg | 103.31 | 101.22 | 101.27 | 2.04 | 0.904 |
| Dressing percentage, % | 75.54 | 72.79 | 74.75 | 0.49 | 0.058 |
| Carcass length, cm | 111.35 | 111.43 | 109.13 | 0.82 | 0.463 |
| Backfat thickness, cm | |||||
| First rib | 3.29 | 3.22 | 3.49 | 0.11 | 0.643 |
| Last rib | 2.19 | 2.49 | 2.61 | 0.08 | 0.112 |
| Last lumbar vertebra | 1.58 | 1.42 | 1.57 | 0.07 | 0.668 |
| Average backfat | 2.35 | 2.38 | 2.55 | 0.07 | 0.522 |
| Eye muscle area, cm2 | 54.74 | 56.94 | 58.64 | 1.47 | 0.587 |
| Abdominal fat, kg | 2.58 | 2.85 | 2.20 | 0.12 | 0.100 |
| Abdominal fat index | 1.90 | 2.06 | 1.63 | 0.09 | 0.165 |
ADG = average daily gain; ADFI = average daily feed intake; F:G = feed-to-gain ratio.
Results are presented as the mean and SEM (n = 6).
Abdominal fat index (%) = abdominal fat weight/live weight × 100.
Effect of dietary lycopene supplementation on meat quality of finishing pigs.
| Item | Lycopene, mg/kg | SEM | |||
|---|---|---|---|---|---|
| 0 | 100 | 200 | |||
| pH45min | 6.49 | 6.53 | 6.52 | 0.05 | 0.961 |
| pH24h | 5.61 | 5.57 | 5.59 | 0.01 | 0.329 |
| L∗ (lightness) | 42.17b | 41.17a | 41.16a | 0.13 | ˂0.001 |
| a∗ (redness) | 4.10a | 4.32a | 4.58b | 0.06 | ˂0.001 |
| b∗ (yellowness) | 2.97b | 2.50ab | 2.45a | 0.09 | 0.029 |
| Drip loss, % | 2.58 | 2.82 | 2.75 | 0.05 | 0.199 |
| Cooking loss, % | 33.54 | 34.38 | 32.85 | 0.73 | 0.719 |
| Shear force, kg | 5.53 | 5.44 | 5.09 | 0.13 | 0.387 |
| Marbling score | 2.83 | 3.67 | 3.00 | 0.23 | 0.319 |
| Intramuscular fat content, % | 3.26a | 3.56ab | 3.98b | 0.12 | 0.047 |
| Crude protein content, % | 22.93a | 24.74b | 25.30b | 0.28 | ˂0.001 |
| Moisture, % | 70.87 | 70.02 | 69.61 | 0.42 | 0.486 |
Results are presented as the mean and SEM (n = 6).
a, b Values within a row with different superscripts differ significantly at P < 0.05.
Effect of dietary lycopene supplementation on antioxidant capacity of finishing pigs.1
| Item | Lycopene, mg/kg | SEM | |||
|---|---|---|---|---|---|
| 0 | 100 | 200 | |||
| Serum | |||||
| MDA, nmol/mL | 3.52 | 2.72 | 3.10 | 0.21 | 0.350 |
| T-AOC, U/mL | 0.42a | 0.45b | 0.43ab | 0.00 | 0.014 |
| T-SOD, U/mL | 137.97a | 159.63b | 159.31ab | 4.52 | 0.011 |
| GSH-Px, U/mL | 2,888.69a | 3,142.86ab | 3,239.77b | 54.73 | 0.015 |
| CAT, U/mL | 3.68a | 4.15a | 5.42b | 0.25 | 0.001 |
| Liver | |||||
| MDA, nmol/mg prot | 3.97b | 2.72a | 2.51a | 0.25 | 0.018 |
| T-AOC, U/mg prot | 0.63a | 0.64ab | 0.65b | 0.00 | 0.006 |
| T-SOD, U/mg prot | 1,404.42a | 1,619.14b | 1,481.39a | 26.56 | ˂0.001 |
| GSH-Px, U/mg prot | 98.92a | 118.78b | 115.10b | 2.50 | ˂0.001 |
| CAT, U/mg prot | 7.04a | 7.94b | 7.64ab | 0.15 | 0.030 |
| LD muscle | |||||
| MDA, nmol/mg prot | 1.21c | 1.01b | 0.81a | 0.05 | ˂0.001 |
| T-AOC, U/mg prot | 0.47 | 0.48 | 0.48 | 0.00 | 0.237 |
| T-SOD, U/mg prot | 49.84a | 49.82a | 54.10b | 0.60 | ˂0.001 |
| GSH-Px, U/mg prot | 8.85 | 11.32 | 13.83 | 0.98 | 0.110 |
| CAT, U/mg prot | 0.68a | 0.86ab | 1.14b | 0.07 | 0.026 |
T-AOC = total antioxidant capacity; T-SOD = total superoxide dismutase; GSH-Px = glutathione peroxidase; CAT = catalase; MDA = malonaldehyde; prot = protein.
a,b,c Values within a row with different superscripts differ significantly at P < 0.05.
Results are presented as the mean and SEM (n = 6).
Fig. 1Effect of dietary lycopene supplementation on the mRNA levels of antioxidant enzyme related genes in longissimus dorsi (LD) muscle of finishing pigs. Real-time quantitative PCR analyzed the mRNA expressions of superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), catalase (CAT), glutathione peroxidase 1 (GPX1), glutathione S-transferase (GST), glutathione reductase (GR), nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1). Data are presented as the mean and SEM (n = 6). a, b, c Bar with different letter indicates significant difference (P < 0.05).
Fig. 2Effect of dietary lycopene supplementation on muscle fiber type conversion in longissimus dorsi (LD) muscle of finishing pigs. (A) Western blotting measured the protein expression levels of slow myosin heavy chain (MyHC) and fast MyHC. (B) Western blotting measured the protein expression level of myoglobin. (C) Immunofluorescence analyzed the percentage of slow-twitch fiber and fast-twitch fiber. The white scale bars represent 100 μm. (D) Real-time quantitative PCR analyzed the mRNA levels of MyHC I, MyHC IIa, MyHC IIx, MyHC IIb and troponin I type 1 (TNNI1). (E to G) The activities of succinic dehydrogenase (SDH), malate dehydrogenase (MDH) and lactate dehydrogenase (LDH) enzymes. (H) The mRNA levels of mitochondrial biogenesis related genes including cytochrome c (Cytc), nuclear respiratory factor 1 (NRF1), mitochondrial transcription factor A (TFAM), mitochondrial transcription factor B1 (TFB1M), citrate synthase (CS) and cyclooxygenase 1 (COX1). (I) The protein level of Cytc. Data are presented as the mean and SEM (n = 6). a, b, c Bar with a different letter indicates significant difference (P < 0.05).
Fig. 3Effect of dietary lycopene supplementation on AMP-activated protein kinase (AMPK) signaling pathway in longissimus dorsi (LD) muscle of finishing pigs. (A) The protein expressions of AMP-activated protein kinase (AMPK) and phospho-AMP-activated protein kinase (p-AMPK). (B) The protein expressions of nuclear respiratory factor 1 (NRF1), calcium/calmodulin-dependent protein kinase β (CaMKKβ), sirtuin1 (Sirt1) and peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α). (C) The mRNA expressions of AMP-activated protein kinase α1 (AMPKα1), AMP-activated protein kinase α2 (AMPKα2), sirtuin1 (Sirt1) and peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α). Data are presented as the mean and SEM (n = 6). a, b, c Bar with different letter indicates significant difference (P < 0.05).